ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

COYA Coya Therapeutics Inc

8.08
-0.13 (-1.58%)
2024年5月14日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Coya Therapeutics Inc COYA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.13 -1.58% 8.08 06:30:01
始値 安値 高値 終値 前日終値
8.37 8.01 8.65 8.08 8.21
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1005:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:20EDGAR2Form 8-K - Current report
2024/5/1005:10BWCoya Therapeutics Provides a Corporate Update and Reports..
2024/5/0906:21EDGAR2Form 8-K - Current report
2024/4/2621:15BWCoya Therapeutics Presents Updated ALS Biomarker Data at the..
2024/4/2221:15BWCoya Therapeutics to Participate in the Mizuho Neuroscience..
2024/4/1821:15BWCoya Therapeutics to Participate in the 3rd Annual ALS Drug..
2024/4/0821:15BWCoya Therapeutics Scientific Advisory Board Chairman Dr...
2024/3/1921:15BWCoya Therapeutics Provides a Corporate Update and Reports..
2024/3/1222:00BWCoya Therapeutics to Participate in BTIG Fireside Discussion
2024/3/1221:00BWCoya Therapeutics Presents ALS Biomarker Data at Society of..
2024/3/0622:15BWCoya Therapeutics Presents Biomarker Data on..
2024/3/0610:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2922:15BWCoya Therapeutics to Present Data on Immune System and..
2024/2/2222:15BWCoya Therapeutics to Present Novel Biomarker Survival Data..
2024/2/2122:15BWCoya Therapeutics Issues Letter to Stockholders Highlighting..
2024/2/1322:15BWCoya Therapeutics Licenses Intellectual Property Rights for..
2024/2/0310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2922:15BWCoya Therapeutics SAB Chairman Dr. Stanley Appel, M.D...
2024/1/2008:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2008:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2008:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1922:15EDGAR2Form 8-K - Current report
2024/1/1822:15BWCoya Therapeutics to Participate in Upcoming Chardan Biotech..
2024/1/1706:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/1/1622:15BWCoya Therapeutics Announces Pipeline Expansion of COYA 302..
2024/1/1618:06PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
2024/1/1617:59PRNUSDISCO Pharmaceuticals launches as the surfaceome company..
2024/1/0522:00BWCoya Therapeutics Announces Successful Pre-IND and Type C..
2024/1/0506:46EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/2023:46EDGAR2Form D - Notice of Exempt Offering of Securities
2023/12/2022:35EDGAR2Form 8-K - Current report
2023/12/2022:30BWMr. Wilbur L. Ross, Former United States Secretary of..
2023/12/1322:00BWCoya Therapeutics’ CEO Dr. Howard Berman’s Letter to..
2023/12/1222:00BWCoya Therapeutics Announces Closing of $26.5 Million Private..
2023/12/0621:30EDGAR2Form 8-K - Current report
2023/12/0621:05BWCoya Therapeutics Announces $26.5 Million Private Placement
2023/12/0621:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
2023/11/0823:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0823:03EDGAR2Form 8-K - Current report
2023/11/0823:00BWCoya Therapeutics, Inc. Provides Business Update and Reports..
2023/10/2722:00BWCoya Announces Acceptance of Oral Presentation, “Regulatory..
2023/10/0921:00BWCoya Therapeutics (Coya) Announces Completion of Enrollment..
2023/10/0522:00BWCoya Therapeutics Presents New Experimental Data Supporting..
2023/10/0322:00BWCoya Therapeutics Announces the Presentation of Human..
2023/9/2722:00BWCoya Therapeutics to Present at the LD Micro Investor..
2023/9/2222:00BWCoya Therapeutics Licenses Exclusive Worldwide rights to..
2023/9/0722:15BWCoya Therapeutics Successfully Engineers Regulatory T Cell..
2023/8/3121:00BWCoya Therapeutics Announces Publication of Potential Novel..

最近閲覧した銘柄

Delayed Upgrade Clock